Bloomberg Markets & Finance via Youtube

Oct.15 — Johns Hopkins International Vaccine Access Center Executive Director William Moss discusses ways to safely accelerate the coronavirus vaccine development process, challenges in delivering a vaccine to patients, and the differences between antibody treatments and a vaccine. He speaks with Bloomberg’s Francine Lacqua on “Bloomberg Surveillance.” The Bloomberg School of Public Health is supported by Michael R. Bloomberg, founder and majority owner of Bloomberg LP, the parent company of Bloomberg News.

READ ALSO  SE: JPM’s Normand: Markets Reflect Optimism of Big Stimulus by January